Measles immunity and vaccination policy in Catalonia (Q50147851)

25 February 2018

title

Measles immunity and vaccination policy in Catalonia (English)

1 reference

25 February 2018

1 reference

5

1 reference

25 February 2018

author name string

Domínguez A

1

1 reference

25 February 2018

Vidal J

2

1 reference

25 February 2018

Plans P

3

1 reference

25 February 2018

Carmona G

4

1 reference

25 February 2018

Batalla J

6

1 reference

25 February 2018

Salleras L

7

1 reference

25 February 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

25 February 2018

published in

Vaccine

1 reference

25 February 2018

volume

17

1 reference

25 February 2018

issue

6

1 reference

25 February 2018

page(s)

530-534

1 reference

25 February 2018

Mortality by cause for eight regions of the world: Global Burden of Disease Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

A persistent outbreak of measles despite appropriate prevention and control measures

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Continuing measles transmission in students despite school-based outbreak control program.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Measles outbreak in a fully immunized secondary-school population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Herd immunity and measles.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Mathematical modeling and attempts to eliminate measles: a tribute to the late Professor George Macdonald

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Herd immunity: history, theory, practice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Immunisation and herd immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Seroepidemiology of measles in Catalonia (Spain) 1985–1986

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Surveillance of antibody to measles, mumps, and rubella by age.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Measles reimmunization in children seronegative after initial immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Measles vaccination policy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Successes and failures in measles control

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Measles vaccine: a 27-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

The role of secondary vaccine failures in measles outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Investigation of a measles outbreak in a fully vaccinated school population including serum studies before and after revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Secondary failure rates of measles vaccines: a metaanalysis of published studies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

No measles in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Harmony on the second dose of measles vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Measles elimination in the Americas. Evolving strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

Exanthem subitum (roseola infantum) misdiagnosed as measles or rubella [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900230-8

7 January 2021

10.1016/S0264-410X(98)00230-8

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018